Early studies reported that the protective activity of HSA against erythrocyte membrane lipid peroxidation is decreased in patients with renal failure [7], [9] and that this noxious state can be ameliorated by administration of HSA from healthy subjects [9]. The gene discussed is ALB; the disease is kidney failure.